• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用Ac-PHQGQHIGVSK-琼脂糖纯化贝伐单抗的方案。

Protocol for bevacizumab purification using Ac-PHQGQHIGVSK-agarose.

作者信息

Barredo Gabriela R, Giudicessi Silvana L, Martínez Ceron María C, Saavedra Soledad L, Rodríguez Santiago, Filgueira Risso Lucas, Erra-Balsells Rosa, Mahler Gustavo, Albericio Fernando, Cascone Osvaldo, Camperi Silvia A

机构信息

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Junín 956, 1113, Buenos Aires, Argentina.

CONICET-Universidad de Buenos Aires, Instituto de Nanobiotecnología (NANOBIOTEC), Facultad de Farmacia y Bioquímica, Junín 956, 1113, Buenos Aires, Argentina.

出版信息

MethodsX. 2019 Dec 16;7:100769. doi: 10.1016/j.mex.2019.12.010. eCollection 2020.

DOI:10.1016/j.mex.2019.12.010
PMID:32021822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6993007/
Abstract

Bevacizumab is a monoclonal antibody, produced in CHO cells, used for the treatment of many human cancers. It is an anti-vascular endothelial growth factor (antsi-VEGF) that blocks the growth of tumor blood vessels. Nowadays its purification is achieved by affinity chromatography (AC) using protein A which is a very expensive ligand. On the other hand, the peptide Ac-PHQGQHIGVSK contained in the VEGF fragment binds bevacizumab with high affinity. This short peptide ligand has higher stability and lower cost than protein A and it can be prepared very easily by solid phase peptide synthesis. The present protocol describes the synthesis of Ac-PHQGQHIGVSK-agarose and its use for affinity chromatography purification of bevacizumab from a clarified CHO cell culture. •Ac-PHQGQHIGVSK-agarose capacity and selectivity are equivalent to those of protein A matrices.•The peptide ligand shows a greater stability and lower cost. The lack of Trp, Met or Cys in the peptide ligand prevents its oxidation and extends the useful life of the chromatographic matrix.•Mild conditions used during chromatography preserved the integrity of bevacizumab.

摘要

贝伐单抗是一种在CHO细胞中产生的单克隆抗体,用于治疗多种人类癌症。它是一种抗血管内皮生长因子(抗VEGF),可阻断肿瘤血管的生长。如今,其纯化是通过使用蛋白A的亲和色谱法(AC)实现的,而蛋白A是一种非常昂贵的配体。另一方面,VEGF片段中包含的肽Ac-PHQGQHIGVSK与贝伐单抗具有高亲和力。这种短肽配体比蛋白A具有更高的稳定性和更低的成本,并且可以通过固相肽合成非常容易地制备。本方案描述了Ac-PHQGQHIGVSK-琼脂糖的合成及其用于从澄清的CHO细胞培养物中亲和色谱纯化贝伐单抗的方法。•Ac-PHQGQHIGVSK-琼脂糖的容量和选择性与蛋白A基质相当。•肽配体显示出更高的稳定性和更低的成本。肽配体中缺乏色氨酸、甲硫氨酸或半胱氨酸可防止其氧化并延长色谱基质的使用寿命。•色谱过程中使用的温和条件保持了贝伐单抗的完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dccf/6993007/1c5dc58d5b18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dccf/6993007/08f047607948/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dccf/6993007/1c5dc58d5b18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dccf/6993007/08f047607948/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dccf/6993007/1c5dc58d5b18/gr1.jpg

相似文献

1
Protocol for bevacizumab purification using Ac-PHQGQHIGVSK-agarose.使用Ac-PHQGQHIGVSK-琼脂糖纯化贝伐单抗的方案。
MethodsX. 2019 Dec 16;7:100769. doi: 10.1016/j.mex.2019.12.010. eCollection 2020.
2
A short peptide fragment of the vascular endothelial growth factor as a novel ligand for bevacizumab purification.一种血管内皮生长因子的短肽片段,作为贝伐单抗纯化的新型配体。
Protein Expr Purif. 2020 Jan;165:105500. doi: 10.1016/j.pep.2019.105500. Epub 2019 Sep 19.
3
Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.肽亲和色谱法在治疗性抗体纯化中的应用。
Int J Pept Res Ther. 2021;27(4):2905-2921. doi: 10.1007/s10989-021-10299-5. Epub 2021 Oct 19.
4
A new tetrapeptide biomimetic chromatographic resin for antibody separation with high adsorption capacity and selectivity.一种用于抗体分离的新型四肽仿生色谱树脂,具有高吸附容量和选择性。
J Chromatogr A. 2019 Oct 25;1604:460474. doi: 10.1016/j.chroma.2019.460474. Epub 2019 Aug 22.
5
Recombinant human follicle stimulating hormone purification by a short peptide affinity chromatography.通过短肽亲和色谱法纯化重组人促卵泡激素
J Pept Sci. 2018 Nov;24(11):e3128. doi: 10.1002/psc.3128. Epub 2018 Oct 5.
6
Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.靶向血管内皮生长因子的单克隆抗体:癌症治疗的现状与未来挑战
BioDrugs. 2009;23(5):289-304. doi: 10.2165/11317600-000000000-00000.
7
Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.将鼠源等效的贝伐单抗(阿瓦斯汀)(一种抗血管内皮生长因子单克隆抗体)进行基因传递,以抑制免疫缺陷小鼠体内人类肿瘤的生长。
Hum Gene Ther. 2008 Mar;19(3):300-10. doi: 10.1089/hum.2007.109.
8
Innovative next-generation monoclonal antibody purification using activated carbon: A challenge for flow-through and column-free processes.创新的下一代单克隆抗体使用活性炭纯化:对流过滤和无柱工艺的挑战。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 15;1121:72-81. doi: 10.1016/j.jchromb.2019.05.009. Epub 2019 May 10.
9
Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII.使用肽配体的亲和色谱步骤用于cGMP生产因子VIII的方法开发与验证。
Biotechnol Bioeng. 2004 Aug 5;87(3):400-12. doi: 10.1002/bit.20124.
10
Novel peptide ligand with high binding capacity for antibody purification.新型肽配体,具有高抗体纯化结合容量。
J Chromatogr A. 2012 Feb 17;1225:158-67. doi: 10.1016/j.chroma.2011.12.074. Epub 2011 Dec 29.

引用本文的文献

1
Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery.使用色谱方法纯化单克隆抗体:提高纯度和回收率
Adv Pharm Bull. 2025 Jan 5;15(1):27-45. doi: 10.34172/apb.43967. eCollection 2025 Apr.
2
Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.肽亲和色谱法在治疗性抗体纯化中的应用。
Int J Pept Res Ther. 2021;27(4):2905-2921. doi: 10.1007/s10989-021-10299-5. Epub 2021 Oct 19.

本文引用的文献

1
A short peptide fragment of the vascular endothelial growth factor as a novel ligand for bevacizumab purification.一种血管内皮生长因子的短肽片段,作为贝伐单抗纯化的新型配体。
Protein Expr Purif. 2020 Jan;165:105500. doi: 10.1016/j.pep.2019.105500. Epub 2019 Sep 19.
2
VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.血管内皮生长因子(VEGF)与人源化中和抗体的Fab片段:复合物的2.4埃分辨率晶体结构及界面的突变分析
Structure. 1998 Sep 15;6(9):1153-67. doi: 10.1016/s0969-2126(98)00116-6.
3
Detection of secondary amines on solid phase.
固相上仲胺的检测
Pept Res. 1995 Jul-Aug;8(4):236-7.
4
A spectrophotometric assay for soluble and immobilized N-hydroxysuccinimide esters.一种用于可溶性和固定化N-羟基琥珀酰亚胺酯的分光光度测定法。
Anal Biochem. 1982 Nov 1;126(2):433-5. doi: 10.1016/0003-2697(82)90540-1.
5
Prediction of the performance of preparative affinity chromatography.制备型亲和色谱性能的预测
J Chromatogr. 1984 Aug 3;297:179-202. doi: 10.1016/s0021-9673(01)89041-5.
6
Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.用于检测肽固相合成中游离末端氨基的颜色测试。
Anal Biochem. 1970 Apr;34(2):595-8. doi: 10.1016/0003-2697(70)90146-6.
7
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
8
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.一种利用蛋白质 - 染料结合原理对微克级蛋白质进行定量的快速灵敏方法。
Anal Biochem. 1976 May 7;72:248-54. doi: 10.1016/0003-2697(76)90527-3.